Publications by authors named "Chao-Wei Ye"
Article Synopsis
- The study examines how different doses of dapagliflozin affect weight loss in patients with type 2 diabetes mellitus (T2DM), analyzing data from 8,545 patients across 24 trials.
- The results show that the 5 mg/day dose of dapagliflozin led to the most significant weight loss compared to other doses, with faster onset of weight loss as the dosage increased.
- The research provides the first comprehensive analysis of dapagliflozin's impact on weight loss in T2DM patients, demonstrating effective weight loss correlations with higher doses.
